Urinary hepcidin identifies a serum ferritin cut-off for iron supplementation in young athletes: a pilot study

The use of iron supplements should be a judicious choice, primarily when considering the possible risks deriving from an unjustified treatment. In trained athletes, levels of ferritin between 15 and 30 microg/L are frequently observed. Within this ferritin range, the usefulness of iron supplementati...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biological regulators and homeostatic agents Vol. 25; no. 3; p. 427
Main Authors: Borrione, P, Spaccamiglio, A, Rizzo, M, Termine, A, Chierto, E, Campostrini, N, Quaranta, F, Di Gianfrancesco, A, Pigozzi, F
Format: Journal Article
Language:English
Published: Italy 01-07-2011
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The use of iron supplements should be a judicious choice, primarily when considering the possible risks deriving from an unjustified treatment. In trained athletes, levels of ferritin between 15 and 30 microg/L are frequently observed. Within this ferritin range, the usefulness of iron supplementation is still controversial. The aim of the present study is to evaluate the clinical usefulness of hepcidin assessment in the analysis of the iron status of young non-anemic athletes. Fifty young athletes were enrolled. The subjects were divided into 4 groups according to their ferritin levels. No statistically significant difference was found regarding hepcidin levels between athletes with ferritin lower than 15 microg/L and those in the 15-30 microg/L range. Similarly, no difference was found between athletes with ferritin higher than 50 microg/L and those in the 30-50 microg/L range. On the contrary, statistically significant differences were found between athletes with ferritin levels ranging from 15 to 30 microg/L and those in the 30-50 microg/L range. The present study suggests that serum ferritin levels below 30 microg/L indicate an asymptomatic iron deficiency status inhibiting hepcidin expression and that 30 microg/L should be considered the ferritin cut-off when considering an iron supplementation in young athletes.
AbstractList The use of iron supplements should be a judicious choice, primarily when considering the possible risks deriving from an unjustified treatment. In trained athletes, levels of ferritin between 15 and 30 microg/L are frequently observed. Within this ferritin range, the usefulness of iron supplementation is still controversial. The aim of the present study is to evaluate the clinical usefulness of hepcidin assessment in the analysis of the iron status of young non-anemic athletes. Fifty young athletes were enrolled. The subjects were divided into 4 groups according to their ferritin levels. No statistically significant difference was found regarding hepcidin levels between athletes with ferritin lower than 15 microg/L and those in the 15-30 microg/L range. Similarly, no difference was found between athletes with ferritin higher than 50 microg/L and those in the 30-50 microg/L range. On the contrary, statistically significant differences were found between athletes with ferritin levels ranging from 15 to 30 microg/L and those in the 30-50 microg/L range. The present study suggests that serum ferritin levels below 30 microg/L indicate an asymptomatic iron deficiency status inhibiting hepcidin expression and that 30 microg/L should be considered the ferritin cut-off when considering an iron supplementation in young athletes.
Author Borrione, P
Chierto, E
Quaranta, F
Pigozzi, F
Spaccamiglio, A
Termine, A
Di Gianfrancesco, A
Rizzo, M
Campostrini, N
Author_xml – sequence: 1
  givenname: P
  surname: Borrione
  fullname: Borrione, P
  organization: Department of Health Sciences, University of Rome Foro Italico, Rome, Italy
– sequence: 2
  givenname: A
  surname: Spaccamiglio
  fullname: Spaccamiglio, A
– sequence: 3
  givenname: M
  surname: Rizzo
  fullname: Rizzo, M
– sequence: 4
  givenname: A
  surname: Termine
  fullname: Termine, A
– sequence: 5
  givenname: E
  surname: Chierto
  fullname: Chierto, E
– sequence: 6
  givenname: N
  surname: Campostrini
  fullname: Campostrini, N
– sequence: 7
  givenname: F
  surname: Quaranta
  fullname: Quaranta, F
– sequence: 8
  givenname: A
  surname: Di Gianfrancesco
  fullname: Di Gianfrancesco, A
– sequence: 9
  givenname: F
  surname: Pigozzi
  fullname: Pigozzi, F
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22023767$$D View this record in MEDLINE/PubMed
BookMark eNo1T8tKAzEUzaJiH_oLkh8YSG-imbiT4gsK3VhwV5LJjY3MZEIei_69AZWzOBzOA86aLMIccEFWjCveKSk-l2Sd8zdjggspr8kSgAGXD3JFwjH5oNOFnjEO3vpAvcVQvPOYqaYZU52ow5R8ad5QSzc7R92cqE9zoLnGOOLUGrr4plvmMtfwRXU5j1gwP7aR6Me50FyqvdyQK6fHjLd_vCHHl-eP3Vu3P7y-7572XYQtK53ijvcgGLDegNFmQKNtg7BGS8eUGSzw3rjeKVQGrDDADArmBtgq5e5hQ-5-d2M1E9pTTH5qL0__x-EHrMRZPQ
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Biology
ExternalDocumentID 22023767
Genre Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
53G
5GY
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CGR
CUY
CVF
DIK
ECM
EIF
F5P
FRP
NPM
NQS
OK1
P2P
SV3
TR2
ID FETCH-LOGICAL-p210t-93f38240208b2babcebadada4dba7f09bcd238bf8f9e9b2d4b20be40fc2199f52
ISSN 0393-974X
IngestDate Wed Mar 27 02:17:51 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p210t-93f38240208b2babcebadada4dba7f09bcd238bf8f9e9b2d4b20be40fc2199f52
PMID 22023767
ParticipantIDs pubmed_primary_22023767
PublicationCentury 2000
PublicationDate 2011 Jul-Sep
PublicationDateYYYYMMDD 2011-07-01
PublicationDate_xml – month: 07
  year: 2011
  text: 2011 Jul-Sep
PublicationDecade 2010
PublicationPlace Italy
PublicationPlace_xml – name: Italy
PublicationTitle Journal of biological regulators and homeostatic agents
PublicationTitleAlternate J Biol Regul Homeost Agents
PublicationYear 2011
SSID ssj0043477
Score 1.9676841
Snippet The use of iron supplements should be a judicious choice, primarily when considering the possible risks deriving from an unjustified treatment. In trained...
SourceID pubmed
SourceType Index Database
StartPage 427
SubjectTerms Adolescent
Antimicrobial Cationic Peptides - urine
Athletes
Dietary Supplements
Female
Ferritins - blood
Hepcidins
Humans
Iron - administration & dosage
Male
Pilot Projects
Title Urinary hepcidin identifies a serum ferritin cut-off for iron supplementation in young athletes: a pilot study
URI https://www.ncbi.nlm.nih.gov/pubmed/22023767
Volume 25
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La-MwEBZJl0IvS3f73gc67M0YHFuO7N6Wbkovu4dtCr0VjS21hiY2jXNof_3OSFbjZCm0h2IwjmSM0HySZiYz3zD2I9NoNJgcQlkqCIWCKFQyAlzuKZ6-ShUypdzhi0v55zr7NRGTwcAXSV21vauksQ1lTZmzb5D280exAZ9R5nhHqeP9VXK_enAZtne6KSo8mIKqdAFBehGoAIewnAWG6BhbikBftmFtjI01pHy3YEFFPl1AuY-CfKT9ILBBF60LoFNBU93XbY-a9n_t1pE7WQQ8uHL3VNWHvPR39UzXlMdETLG3nkrKhSzisOr5etrZJRr1hZpVt_dVveZ7_Vs9PdVr_typDezpeWjLlXtWem9Gl8WVJyHaONf9HdqlRndITHrbrXC8Aj2xNjMr15iqwsvxK3o32LZ915ANUXci9frstz_ZRSJsJc_nMRKTdPf-hlVitZPpLvvYTTz_6fDwiQ30_DPbdoVGH_fYvEMF96jgK1RwxS0quEcF71DBERWcUME3UMHxHYsK7lFxih-xmOAWE_vs6nwyPbsIu0obYYMmfxvmiUky-p8tyiAGBYUGVeIlSlDSRDkUJap2YDKT6xziUkAcAa5yU-CBl5s0PmBbc8THEeNQSEkcQGk6BjGKpUrxt05Go2KcgjDRMTt0E3XTODqVGz-FJy_2fGE7K6x8ZR8MrlX9jQ0X5fK7ldA_E9hpRw
link.rule.ids 782
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Urinary+hepcidin+identifies+a+serum+ferritin+cut-off+for+iron+supplementation+in+young+athletes%3A+a+pilot+study&rft.jtitle=Journal+of+biological+regulators+and+homeostatic+agents&rft.au=Borrione%2C+P&rft.au=Spaccamiglio%2C+A&rft.au=Rizzo%2C+M&rft.au=Termine%2C+A&rft.date=2011-07-01&rft.issn=0393-974X&rft.volume=25&rft.issue=3&rft.spage=427&rft_id=info%3Apmid%2F22023767&rft_id=info%3Apmid%2F22023767&rft.externalDocID=22023767
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0393-974X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0393-974X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0393-974X&client=summon